These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2745186)
1. Effect of combination therapy of radiation and local administration of OK-432 on a murine fibrosarcoma. Mukai M; Ando K; Koike S; Nagao K Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):125-30. PubMed ID: 2745186 [TBL] [Abstract][Full Text] [Related]
2. [Combined effect of the topical administration of OK-432 with radiation on the C3H mouse fibrosarcoma (NFSa)--TCD50 and the mechanism of action]. Mukai M; Ando K; Koike S; Nagao K; Isono K Gan To Kagaku Ryoho; 1986 Dec; 13(12):3432-5. PubMed ID: 3789754 [TBL] [Abstract][Full Text] [Related]
3. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)]. Mukai M; Ando K; Koike S Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):631-5. PubMed ID: 3355184 [TBL] [Abstract][Full Text] [Related]
4. [Combination therapy of local administration of OK-432 and radiation on a murine fibrosarcoma (NFSa)--combination effect and histological examination]. Mukai M; Ando K; Koike S; Ishikawa T; Ryu M; Nagashima T; Nagao K; Isono K Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):556-62. PubMed ID: 3954378 [TBL] [Abstract][Full Text] [Related]
5. [The effect of OK-432 on modifying a spontaneous lung metastasis from murine fibrosarcomas]. Ito H; Yamada S; Nishiguchi I; Shigematsu N; Nakayama T; Kuribayashi T; Hashimoto S Gan No Rinsho; 1990 Aug; 36(9):993-7. PubMed ID: 2381054 [TBL] [Abstract][Full Text] [Related]
6. Augmentation of mouse natural killer cell activity by combined hyperthermia and streptococcal preparation, OK-432 (Picibanil) treatment. Taradi M; Urano M; Taradi SK; Maruyama Y Int J Hyperthermia; 1991; 7(4):653-65. PubMed ID: 1919160 [TBL] [Abstract][Full Text] [Related]
7. [Modification of spontaneous lung metastasis by local radiation combined with or without immunomodifier]. Shigematsu N Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Sep; 50(9):1139-46. PubMed ID: 2247355 [TBL] [Abstract][Full Text] [Related]
8. [Prevention of peritoneal recurrence by combined intra-peritoneal and intra-tumoral injections of OK-432]. Baba H; Tsujitani S; Korenaga D; Kakeji Y; Haraguchi M; Konoe S; Maehara Y; Sugimachi K Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1596-9. PubMed ID: 2389954 [TBL] [Abstract][Full Text] [Related]
9. Evidence that eosinophil infiltration in the OK-432/fibrinogen-injected Meth-A tumor in mice is mediated by locally produced IL-5. Ishiko T; Sakamoto K; Mita S; Kamohara H; Ogawa M Int J Immunopharmacol; 1997 Jul; 19(7):405-12. PubMed ID: 9568545 [TBL] [Abstract][Full Text] [Related]
10. [Studies on the enhancement of anti-tumor activity in patients with cervical cancer by local administration of OK-432]. Yamada Y; Yamamoto K; Wakita K; Shiraki S; Noda K Gan To Kagaku Ryoho; 1986 Dec; 13(12):3427-31. PubMed ID: 3789753 [TBL] [Abstract][Full Text] [Related]
11. Protection of OK-432, a Streptococcus pyogenes preparation, against lethal infection of mice with herpes simplex virus. Harada Y; Kurokawa E; Endo H; Kimura T; Saito M; Sugawara Y; Irie H; Ito K; Fujii M; Shimizu Y Microbiol Immunol; 1989; 33(6):467-77. PubMed ID: 2549347 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of the thermal response of murine tumour and normal tissues by a streptococcal preparation, OK-432 (Picibanil). Urano M; Taradi M; Taradi SK Int J Hyperthermia; 1991; 7(1):113-23. PubMed ID: 2051067 [TBL] [Abstract][Full Text] [Related]
13. [Effect of combined immunotherapy using two different BRMs; OK-432 and IL-2-cultured lymphocytes]. Kan N; Hori T; Ohgaki K; Inamoto T; Kodama H; Tobe T Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1298-306. PubMed ID: 3488027 [TBL] [Abstract][Full Text] [Related]
14. The clinical efficacy of intratumoral OK-432 administration in advanced cancer patients. Toge T; Kuninobu H; Yamaguchi Y; Baba N; Kegoya Y; Hattori T Jpn J Surg; 1988 Nov; 18(6):668-74. PubMed ID: 3266768 [TBL] [Abstract][Full Text] [Related]
15. [The combination therapy of local administration of OK-432 and radiation for 2 cases of lower bile duct carcinoma]. Mukai M; Morita S; Tsunemoto H Nihon Gan Chiryo Gakkai Shi; 1989 Mar; 24(3):617-21. PubMed ID: 2768973 [TBL] [Abstract][Full Text] [Related]
16. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice. Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841 [TBL] [Abstract][Full Text] [Related]
17. Induction thermochemotherapy increases therapeutic gain factor for the fractionated radiotherapy given to a mouse fibrosarcoma. Kuroda M; Urano M; Nishimura Y; Reynolds R Int J Radiat Oncol Biol Phys; 1997 May; 38(2):411-7. PubMed ID: 9226330 [TBL] [Abstract][Full Text] [Related]
18. Radiosensitization of two murine fibrosarcomas with 6-thioguanine. Kim JH; Alfieri AA; Kim SH; Hong SS Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):583-6. PubMed ID: 2318691 [TBL] [Abstract][Full Text] [Related]
19. [Combined effects of cis-DDP and OK-432 on ascitic mastocytoma in mice: optimal period for the administration of OK-432]. Komatsu K; Nakamura W C R Seances Soc Biol Fil; 1986; 180(1):117-20. PubMed ID: 2943364 [TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity. Pogue BW; O'Hara JA; Demidenko E; Wilmot CM; Goodwin IA; Chen B; Swartz HM; Hasan T Cancer Res; 2003 Mar; 63(5):1025-33. PubMed ID: 12615718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]